Brain Wealthy
    What's Hot

    Bridging the Gender Gap: Inspiring Words from the Women Making Waves on Starship | Annie Handrick | | Starship Technologies | March 2023

    March 8, 2023

    AI apps like ChatGPT may finally kill the cover letter

    March 8, 2023

    Snow Crash author Neal Stephenson on the metaverse, making movies, climate fears

    March 6, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    Brain Wealthy
    • Home
    • Anxiety

      FSU psychologist receives $3.7 million grant to combat anxiety in seniors with Alzheimer’s and cognitive impairment

      February 2, 2023

      How anxiety came to dominate the big business of medical marijuana cards in Pa.

      February 2, 2023

      How to Reduce Anxiety in Stressful Situations

      February 2, 2023

      The cat in boots The last wish taught me about anxiety

      February 2, 2023

      Inseparable cat trio with ‘separation anxiety brothers’ find new home

      February 2, 2023
    • Emotion

      Leigh-Anne Pinnock shares emotional post about embarking on her solo career

      February 2, 2023

      Ontario paramedic emotional during last radio call

      February 2, 2023

      A Pianist Faces Death and Recorded Music of Unspeakable Emotions

      February 2, 2023

      Return of home post linking Gichaara to ancestors is emotional for north coast nation

      February 2, 2023

      Mother of two sues New York school district for ‘mental distress’ caused by mask enforcement

      February 2, 2023
    • Neurology

      Gardasil Injection Lawsuit Claims HPV Vaccine Caused Neurological and Autonomic Dysfunction

      February 2, 2023

      REGENXBIO’s Duchenne Therapy RGX-202 Clinical Trial Begins Patient Recruitment

      February 2, 2023

      Aducanumab for the treatment of Alzheimer’s disease

      February 2, 2023

      Potential for Effective Comparative Studies and Treatment Approval in Epilepsy Care: Anup Patel, MD

      February 2, 2023

      Head injury does not predict memory impairment in NFL retirees, UT Southwestern study shows: Newsroom

      February 2, 2023
    • Sleep

      Review: Never Sleep Again: The Elm Street Legacy – Blu-ray

      February 2, 2023

      Get a better night’s sleep with better pillows from The Pillow Bar in Dallas

      February 2, 2023

      Is it okay to sleep with a necklace on?

      February 2, 2023

      Does tart cherry juice improve sleep?

      February 2, 2023

      Social Jet Lag, Sleep Chronotypes, and Why We Gotta Close Our Eyes and Embrace It

      February 2, 2023
    • Brain Research

      spark!Talk – video available online

      February 2, 2023

      Studies have found that obesity-related neurodegeneration mimics Alzheimer’s disease.newsroom

      February 2, 2023

      The Brain Observatory: New Museum to Participate in Museum Month

      February 1, 2023

      who wants to live forever

      February 1, 2023

      UK company makes surprise forays

      February 1, 2023
    • Brain Wealth
      1. Mental Health
      2. View All

      Research project applies a global lens to student mental health

      February 2, 2023

      DC Metro shooting suspect undergoes mental health evaluation after rampage

      February 2, 2023

      Gov. Ho-Chol unveils details of $1 billion plan to overhaul New York State’s mental health care continuum

      February 2, 2023

      Boston, we have a problem: data on mental health and practice come in

      February 2, 2023

      Research project applies a global lens to student mental health

      February 2, 2023

      DC Metro shooting suspect undergoes mental health evaluation after rampage

      February 2, 2023

      Gov. Ho-Chol unveils details of $1 billion plan to overhaul New York State’s mental health care continuum

      February 2, 2023

      Boston, we have a problem: data on mental health and practice come in

      February 2, 2023
    Brain Wealthy
    Home»Neurology»FDA grants accelerated approval to Alzheimer’s disease treatment
    Neurology

    FDA grants accelerated approval to Alzheimer’s disease treatment

    brainwealthy_vws1exBy brainwealthy_vws1exJanuary 6, 2023No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    January 6, 2023

    Read in 2 minutes


    Add topic to email alert

    Get an email when new articles are posted

    Enter your email address to receive an email when new articles are posted .

    Your request could not be processed. Please try again later. If this issue persists, please contact us at customerservice@slackinc.com.

    The FDA has accelerated approval of Leqembi for the treatment of Alzheimer’s disease, making it the second approved treatment for Alzheimer’s disease, the FDA said in a press release.

    Approval is subject to review of Phase 3 data. New England Journal of Medicine The results showed that Leqembi (lecanemab-irmb, Eisai) reduced amyloid markers in early AD and was associated with less cognitive and functional decline.

    Source: Adobe Stock.

    The FDA rapidly approved Leqembi for the treatment of Alzheimer’s disease. Source: Adobe Stock

    “This treatment option is the latest treatment to not only treat the symptoms of Alzheimer’s disease, but to target and influence the underlying disease processes of Alzheimer’s disease.” Billy Dunn, M.D., The director of the Division of Neuroscience at the FDA’s Center for Drug Evaluation and Research said in a release.

    Leqembi was approved under the accelerated pathway used by the FDA to approve drugs for serious conditions when there is an unmet medical need. The agency said Alzheimer’s disease affects her more than 6.5 million Americans.

    “This is encouraging news, but the approval of lecanemab is only the first step.” Howard Filitt, M.D., The Chief Scientific Officer of the Alzheimer’s Drug Discovery Foundation said in a foundation press release: “Therapies for Alzheimer’s disease will only benefit patients if the right drug is given to the right patient at the right time, based on their unique pathology. Is required.”

    The prescribing information for Leqembi contains warnings about amyloid-associated imaging abnormalities (ARIAs) known to occur with this class of antibody, the FDA release said. ARIA is usually asymptomatic, but serious and life-threatening events are rare.

    Additional warnings include the risk of infusion-related reactions, with symptoms such as flu-like symptoms, nausea, vomiting and changes in blood pressure.

    Leqembi’s label says treatment for AD is indicated and should be initiated in people with mild cognitive impairment or mild dementia. In addition, the label states that there are no safety or efficacy data regarding initiation of treatment in early or late stages of disease.

    “By taking it in the early stages of Alzheimer’s disease and slowing the progression of the disease, individuals have more time to participate in their daily lives and live independently,” said Alzheimer’s Association president and CEO. says. Joan Pike, DrPH, said in a release from the association. “This could mean many more months to recognize spouses, children and grandchildren. It could also mean more time for a person to drive safely.” there is [and] Manage your household finances accurately and quickly, participate fully in your hobbies and interests. “


    Add topic to email alert

    Get an email when new articles are posted

    Enter your email address to receive an email when new articles are posted .

    Your request could not be processed. Please try again later. If this issue persists, please contact us at customerservice@slackinc.com.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleThe Recorder – Conway’s Ecoglyph Support Group to Address Climate Anxiety
    Next Article Biden marks Jan. 6 anniversary with emotional tribute and harsh warning
    brainwealthy_vws1ex
    • Website

    Related Posts

    Gardasil Injection Lawsuit Claims HPV Vaccine Caused Neurological and Autonomic Dysfunction

    February 2, 2023

    REGENXBIO’s Duchenne Therapy RGX-202 Clinical Trial Begins Patient Recruitment

    February 2, 2023

    Aducanumab for the treatment of Alzheimer’s disease

    February 2, 2023
    Add A Comment

    Leave A Reply Cancel Reply

    Top Posts

    Subscribe to Updates

    Get the latest sports news from SportsSite about soccer, football and tennis.

    This website provides information about Brain and other things. Keep Supporting Us With the Latest News and we Will Provide the Best Of Our To Makes You Updated All Around The World News. Keep Sporting US.

    Facebook Twitter Instagram Pinterest YouTube
    Top Insights

    Top UK Stocks to Watch: Capita Shares Rise as it Unveils

    January 15, 2021
    8.5

    Digital Euro Might Suck Away 8% of Banks’ Deposits

    January 12, 2021

    Oil Gains on OPEC Outlook That U.S. Growth Will Slow

    January 11, 2021
    Get Informed

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    © 2023 brainwealthy. Designed by brainwealthy.
    • Home
    • Contact us
    • DMCA
    • Privacy Policy

    Type above and press Enter to search. Press Esc to cancel.